Genocea Biosciences, Inc (GNCA)

Etorro trading 970x250
Genocea Biosciences, Inc (GNCA) Logo

About Genocea Biosciences, Inc

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient’s CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient’s tumor. Its products include GEN-011, an adoptive T cell therapy using neoantigen-targeted peripheral cells for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived tumor-specific T cell therapy; and GEN-009, a neoantigen vaccine candidate, delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. Address: 100 Acorn Park Drive, Cambridge, MA, United States, 02140

Genocea Biosciences, Inc News and around…

Latest news about Genocea Biosciences, Inc (GNCA) common stock and company :

The Petri Dish: Janssen inks two local deals, Biogen licenses new drug
06 Jan, 2022 Yahoo! Finance

While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings.

Genocea to Present at Upcoming Investor Conferences
05 Jan, 2022 Yahoo! Finance

CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following conferences in January. Conferences: Event:Longwood Healthcare Leaders Winter Webconference - DetailsTopic 1:Innovation in Cell TherapyFormat:PanelDate:Thursday, January 6, 2022Time:1:30 PM ETTopic 2:Making a Big Impact With Limited ResourcesFormat:Date:Ti

Genocea Biosciences Provides Corporate Update
04 Jan, 2022 Yahoo! Finance

Enters into Inhibigen™ R&D collaboration and option agreement with Janssen Reports progress on the GEN-011 TiTAN™ trial CAMBRIDGE, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, has entered into an R&D collaboration and option agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to explore the immunogenicity of neoantigens and t

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
29 Dec, 2021 FinancialContent

Gainers Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 12.6% to $1.34 during Wednesday's pre-market ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
28 Dec, 2021 FinancialContent

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 10.9% to $0.6 during Tuesday's after-market session. The market value of ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
28 Dec, 2021 FinancialContent

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 41.2% to $3.29 during Tuesday's pre-market ...

51 Biggest Movers From Yesterday
28 Dec, 2021 FinancialContent

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a ...

34 Stocks Moving In Monday's Mid-Day Session
27 Dec, 2021 FinancialContent

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
27 Dec, 2021 FinancialContent

Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 55.35% to $8.42 during Monday's pre-market session. ...

15 Stocks Moving In Monday's Pre-Market Session
27 Dec, 2021 FinancialContent

15 stocks that should be interesting to investors.

54 Biggest Movers From Thursday
27 Dec, 2021 FinancialContent

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products ...

12 Health Care Stocks Moving In Thursday's Intraday Session
23 Dec, 2021 FinancialContent

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 33.33% to $1.96 during Thursday's regular session. As ...

38 Stocks Moving In Thursday's Mid-Day Session
23 Dec, 2021 FinancialContent

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
23 Dec, 2021 FinancialContent

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
23 Dec, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! Christmas is almost here but were aren't slowing down as we dive into the biggest pre-market stock movers for Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

18 Stocks Moving in Thursday's Pre-Market Session
23 Dec, 2021 FinancialContent

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expanded ...

Genocea to Present at the Stifel 2021 Virtual Healthcare Conference
11 Nov, 2021 Yahoo! Finance

CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on Wednesday, November 17th at 1:20 PM ET. A live webcast of the presentation can be accessed by visiting the "Events and Presentations" tab of the investor relations

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
28 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner ...

Genocea Provides Third Quarter 2021 Corporate Update
28 Oct, 2021 Yahoo! Finance

GEN-011 neoantigen-targeted peripheral T cell therapy clinical trial continues Strong presence at the SITC 36th Annual Meeting Conference call today at 8:30 a.m. E.T. CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today provided a business update for the third quarter ended September 30, 2021. “We continue to make significant progress. Most notably, we are very excite

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
24 Oct, 2021 FinancialContent

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma ...

Genocea to Host Third Quarter 2021 Corporate Update Conference Call & Webcast
21 Oct, 2021 Yahoo! Finance

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies, will host its third quarter 2021 corporate update conference call and live audio webcast on Thursday, October 28th at 8:30 a.m. E.T. Interested participants may access the conference call by dialing (844) 826-0619 (domestic) or (315) 625-6883 (international) and referring to conference ID number 8729366. To join the live webc

Genocea to Present at Upcoming Conferences
28 Sep, 2021 FinancialContent
Jennifer Herron, of ADC Therapeutics, Joins Genocea Biosciences' Board of Directors
13 Sep, 2021 FinancialContent
Genocea to Present at Upcoming Scientific and Investor Conferences
07 Sep, 2021 FinancialContent
Do Options Traders Know Something About Genocea (GNCA) Stock We Don't?
23 Aug, 2021 Yahoo! Finance

Investors need to pay close attention to Genocea (GNCA) stock based on the movements in the options market lately.

12 Health Care Stocks Moving In Thursday's After-Market Session
20 Aug, 2021 FinancialContent

Gainers Geovax Labs (NASDAQ:GOVX) shares increased by 30.93% to $5.63 during Thursday's after-market session. Trading volume for ...

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
18 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
17 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Genocea Provides Second Quarter 2021 Corporate Update
29 Jul, 2021 FinancialContent
Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast
22 Jul, 2021 FinancialContent

Genocea Biosciences, Inc (GNCA) is a NASDAQ Common Stock listed in , ,

970x250